Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Amyotrophic lateral sclerosis (ALS) is a degenerative disorder of motor neurons in the cortex, brainstem and spinal cord. Its cause is unknown and it is uniformly fatal, typically within five years. About 10% of cases are inherited as an autosomal dominant trait, with high penetrance after the sixth decade. In most instances, sporadic and autosomal dominant familial ALS (FALS) are clinically similar. We have previously shown that in some but not all FALS pedigrees the disease is linked to a genetic defect on chromosome 21q (refs 8, 9). Here we report tight genetic linkage between FALS and a gene that encodes a cytosolic, Cu/Zn-binding superoxide dismutase (SOD1), a homodimeric metalloenzyme that catalyzes the dismutation of the toxic superoxide anion O2.- to O2 and H2O2 (ref. 10). Given this linkage and the potential role of free radical toxicity in other neurodenegerative disorders, we investigated SOD1 as a candidate gene in FALS. We identified 11 different SOD1 missense mutations in 13 different FALS families.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Long-standing associations of some forms of ALS with mutations in genes coding for superoxide dismutase 1”
Citations
Cites
Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., & Freeman, B. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1620 · Cited by 7,029
Orita, M., Suzuki, Y., Sekiya, T., & Hayashi, K. (1989) · Genomics · doi:10.1016/0888-7543(89)90129-8 · Cited by 3,434
DNA damage and oxygen radical toxicity
Imlay, J. A., & Linn, S. (1988) · Science · doi:10.1126/science.3287616 · Cited by 1,974
Analysis of Human Genetic Linkage.
Edwards, A. W. F., & Ott, J. (1992) · Biometrics · doi:10.2307/2532370 · Cited by 1,691
Functional inactivation of genes by dominant negative mutations
Herskowitz, I. (1987) · Nature · doi:10.1038/329219a0 · Cited by 1,160
Carlioz, A., & Touati, D. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04256.x · Cited by 784
Centre d'Etude du polymorphisme humain (CEPH): Collaborative genetic mapping of the human genome
Dausset, J., Cann, H., Cohen, D., Lathrop, M., Lalouel, J.-M., & White, R. (1990) · Genomics · doi:10.1016/0888-7543(90)90491-c · Cited by 575
Copper,zinc superoxide dismutase is primarily a cytosolic protein in human cells.
Crapo, J. D., Oury, T., Rabouille, C., Slot, J. W., & Chang, L. Y. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10405 · Cited by 503
Richardson, J., Thomas, K. A., Rubin, B. H., & Richardson, D. C. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.4.1349 · Cited by 403
Familial adult motor neuron disease: amyotrophic lateralsclerosis
(1986) · Neurology · doi:10.1212/wnl.36.4.511 · Cited by 401
Self-citation
Research works printed but not linked: 7
- Kurland, L. T. Proc. Staff Meet Mayo Clin. 32, 449–462 (1957).
- Swerts, L. & Van Den Bergh, R. J. J. genet. Hum. 24, 247–255 (1976).
- Fridovich, I. Adv. Enzym. 58, 61–97 (1986).
- Ott, J. Am. hum. Genet. 28, 528–529 (1976).
- Ott, J. Analysis of Human Genetics 203–216 (Johns Hopkins Univ. Press, Baltimore, 1991).
- Hallewell, R. A. et al. in Superoxide Dismutase in Chemistry, Biology and Medicine (ed. Rotilio, G.) 249–256 (Elsevier, 1986).
- Muller, H. in Sixth internat. Congr. Genetics (ed. Jones, D.) 213–255 (Brooklyn Botanic Gardens, Menasha, 1932).
Cited by
Items 401–500 of 1,128
The identity and function of microglia in neurodegeneration
Song, W. M., & Colonna, M. (2018) · Nature Immunology · doi:10.1038/s41590-018-0212-1 · Cited by 308
Garbuzova-Davis, S., Willing, A. E., Zigova, T., Saporta, S., Justen, E. B., Lane, J. C., Hudson, J. E., Chen, N., Davis, C. D., & Sanberg, P. R. (2003) · Journal of Hematotherapy & Stem Cell Research · doi:10.1089/152581603322022990 · Cited by 308
“Secondly, the etiopathology of ALS includes oxidative stress and glutamate excitoxicity (7,8), mutations in the gene for Cu/Zn superoxide dismutase (9), viral infection (10), autoimmune mechanisms (11–13), abnormal accumulations of neurofilaments (14,15), altered glial function (16–19),…”
Moloney, E. B., de Winter, F., & Verhaagen, J. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00252 · Cited by 307
“REVIEW ARTICLE published: 14 August 2014 doi: 10.3389/fnins.2014.00252 ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease”
BackgroundMethodInfluentialDrachman, D. B., Frank, K., Dykes‐Hoberg, M., Teismann, P., Almer, G., Przedborski, S., & Rothstein, J. D. (2002) · Annals of Neurology · doi:10.1002/ana.10374 · Cited by 307
“In celecoxib-treated ALS mice, histological and immunocytochemical examination of the spinal cords showed significant preservation of both large and small neurons in the spinal cords and inhibition of the increase of astrocytic and microglial activity that occurs in ALS.”
BackgroundInfluentialAndersen, P. (1997) · Brain · doi:10.1093/brain/120.10.1723 · Cited by 306
Wang, J., Slunt, H., Gonzales, V., Fromholt, D., Coonfield, M., Copeland, N. G., Jenkins, N. A., & Borchelt, D. R. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg312 · Cited by 306
“Mutations in Cu/Zn SOD1 have been linked to familial amyotrophic lateral sclerosis (FALS) (1), a degenerative disease characterized by loss of lower and upper motor neurons in the motor cortex, brain stem and spinal cord (2).”
BackgroundEPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans
Van Hoecke, A., Schoonaert, L., Lemmens, R., Timmers, M., Staats, K. A., Laird, A. S., Peeters, E., Philips, T., Goris, A., Dubois, B., et al. (2012) · Nature Medicine · doi:10.1038/nm.2901 · Cited by 303
Self-citationNeuroglia in neurodegeneration
Heneka, M. T., Rodríguez, J. J., & Verkhratsky, A. (2010) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.11.004 · Cited by 301
The development of mitochondrial medicine.
Luft, R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8731 · Cited by 300
Cell cycle regulation of neuronal apoptosis in development and disease
Becker, E. B. E., & Bonni, A. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2003.12.005 · Cited by 302
Superoxide dismutase 1 regulates caspase-1 and endotoxic shock
Meissner, F., Molawi, K., & Zychlinsky, A. (2008) · Nature Immunology · doi:10.1038/ni.1633 · Cited by 300
“SOD1 has also been linked to the neurodegenerative disease amyotrophic lateral sclerosi”
BackgroundGlobal Analyses of Sumoylated Proteins in Saccharomyces cerevisiae
Zhou, W., Ryan, J. J., & Zhou, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404173200 · Cited by 300
Glutamate, excitotoxicity and amyotrophic lateral sclerosis
Shaw, P. J., & Ince, P. G. (1997) · Journal of Neurology · doi:10.1007/bf03160574 · Cited by 300
Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease
Albers, D. S., & Flint Beal, M. (2000) · Advances in Dementia Research · doi:10.1007/978-3-7091-6781-6_16 · Cited by 297
Antioxidant-rich diets improve cerebellar physiology and motor learning in aged rats
Bickford, P. C., Gould, T., Briederick, L., Chadman, K., Pollock, A., Young, D., Shukitt-Hale, B., & Joseph, J. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02280-0 · Cited by 298
Tan, C.-F., Eguchi, H., Tagawa, A., Onodera, O., Iwasaki, T., Tsujino, A., Nishizawa, M., Kakita, A., & Takahashi, H. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0206-9 · Cited by 298
“In FALS, mutations in the gene encoding Cu/Zn superoxide dismutase (SOD1) are known to be the most common causative abnormalities [3, 20].”
Endoplasmic reticulum stress and inflammation in the central nervous system
Sprenkle, N. T., Sims, S. G., Sánchez, C. L., & Meares, G. P. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0183-y · Cited by 294
Eyer, J., & Peterson, A. (1994) · Neuron · doi:10.1016/0896-6273(94)90280-1 · Cited by 296
Rodent Models of Amyotrophic Lateral Sclerosis
Philips, T., & Rothstein, J. D. (2015) · Current Protocols in Pharmacology · doi:10.1002/0471141755.ph0567s69 · Cited by 294
“Of major importance are genetic mutations in the superoxide dismutase 1 gene (SOD1, 15% of fALS and 1% to 2% of sALS; Rosen, 1993) and repeat expansions in the gene encoding C9ORF72 (around 40% to 50% of fALS and 10% of sALS; DeJesus-Hernandez et al.”
Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43
Nonaka, T., Kametani, F., Arai, T., Akiyama, H., & Hasegawa, M. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp275 · Cited by 295
Metabolomics: A Global Biochemical Approach to the Study of Central Nervous System Diseases
Kaddurah-Daouk, R., & Krishnan, K. R. R. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.174 · Cited by 293
The Nrf2–ARE cytoprotective pathway in astrocytes
Vargas, M. R., & Johnson, J. A. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409001094 · Cited by 291
Chronic inhibition of superoxide dismutase produces apoptotic death of spinal neurons.
Rothstein, J. D., Bristol, L. A., Hosler, B., Brown, R. H., & Kuncl, R. W. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4155 · Cited by 292
Self-citationChoi, J., Rees, H. D., Weintraub, S. T., Levey, A. I., Chin, L.-S., & Li, L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414327200 · Cited by 291
Bruijn, L. I., Beal, M. F., Becher, M. W., Schulz, J. B., Wong, P. C., Price, D. L., & Cleveland, D. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7606 · Cited by 288
Genetic and molecular basis for copper toxicity
Harris, Z., & Gitlin, J. (1996) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/63.5.836 · Cited by 285
Gene discovery in amyotrophic lateral sclerosis: implications for clinical management
Al-Chalabi, A., van den Berg, L. H., & Veldink, J. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.182 · Cited by 287
A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis
Zhao, Z., Lange, D. J., Voustianiouk, A., MacGrogan, D., Ho, L., Suh, J., Humala, N., Thiyagarajan, M., Wang, J., & Pasinetti, G. M. (2006) · BMC Neuroscience · doi:10.1186/1471-2202-7-29 · Cited by 286
“ALS is an inherited disorder in 10% of patients (familial ALS, FALS) [1].”
BackgroundInfluentialCalabrese, V., Bates, T. E., & Stella, A. M. G. (2000) · Neurochemical Research · doi:10.1023/a:1007604414773 · Cited by 284
Pyruvate Released by Astrocytes Protects Neurons from Copper-Catalyzed Cysteine Neurotoxicity
Wang, X. F., & Cynader, M. S. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-10-03322.2001 · Cited by 285
Calcium dysregulation in amyotrophic lateral sclerosis
Grosskreutz, J., Van Den Bosch, L., & Keller, B. U. (2010) · Cell Calcium · doi:10.1016/j.ceca.2009.12.002 · Cited by 284
Atorino, L., Silvestri, L., Koppen, M., Cassina, L., Ballabio, A., Marconi, R., Langer, T., & Casari, G. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200304112 · Cited by 283
“…forms of neurodegeneration including: Parkinson’s disease (Jenner and Olanow, 1996); Alzheimer’s disease (Behl, 1999); amyotrophic lateral sclerosis (Rosen et al., 1993; Aguirre et al., 1998); Friedreich’s ataxia (Wong et al., 1999); and, more recently, neurodegeneration related to prion…”
BackgroundNeuropathology of amyotrophic lateral sclerosis and its variants
Saberi, S., Stauffer, J. E., Schulte, D. J., & Ravits, J. (2015) · Neurologic Clinics · doi:10.1016/j.ncl.2015.07.012 · Cited by 282
Andersen, P. M., Sims, K. B., Xin, W. W., Kiely, R., O'Neill, G., Ravits, J., Pioro, E., Harati, Y., Brower, R. D., Levine, J. S., et al. (2003) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820310011700 · Cited by 282
“In 1993 a consortium described 11 missense mutations in the gene encoding the cytosolic free-radical scavenging metalloenzyme copper/zinc superoxide dismutase (Cu/Zn-SOD, SOD1, EC 1.15.1.1) in 13 families with FALS.1 The SOD1 gene consists of five exons each of 150–200 nucleotides interspaced with four larger introns.”
BackgroundInfluentialSelf-citationFree Radicals as Mediators of Neuronal Injury
Facchinetti, F., Dawson, V. L., & Dawson, T. M. (1998) · Cellular and Molecular Neurobiology · doi:10.1023/a:1020685903186 · Cited by 281
Study of Gene Regulation by NF-κB and AP-1 in Response to Reactive Oxygen Intermediates
Müller, J. M., Rupec, R. A., & Baeuerle, P. A. (1997) · Methods · doi:10.1006/meth.1996.0424 · Cited by 281
Genetics of familial amyotrophic lateral sclerosis
Valdmanis, P. N., & Rouleau, G. A. (2008) · Neurology · doi:10.1212/01.wnl.0000296811.19811.db · Cited by 281
Self-citationReactive Oxygen Species: Stuck in the Middle of Neurodegeneration
Patten, D. A., Germain, M., Kelly, M. A., & Slack, R. S. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100498 · Cited by 278
“The most direct example is in cases of familial ALS (FALS) in which the antioxidant enzyme SOD1 is mutated [47,48].”
BackgroundDelivery of peptide and protein drugs over the blood–brain barrier
Brasnjevic, I., Steinbusch, H. W. M., Schmitz, C., & Martinez-Martinez, P. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.12.002 · Cited by 279
Mitochondrial dysfunction in a cell culture model of familial amyotrophic lateral sclerosis
Menzies, F. M. (2002) · Brain · doi:10.1093/brain/awf167 · Cited by 277
“In ~20% of familial cases, or 2% of the ALS population as a whole, mutations in the gene encoding the free radical scavenging enzyme Cu/Zn superoxide dismutase (SOD1) have been identi®ed (Rosen et al., 1993).”
BackgroundAtkin, J. D., Farg, M. A., Turner, B. J., Tomas, D., Lysaght, J. A., Nunan, J., Rembach, A., Nagley, P., Beart, P. M., Cheema, S. S., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603393200 · Cited by 279
RetractedEvidence for positive selection in the superoxide dismutase (Sod) region of Drosophila melanogaster.
Hudson, R. R., Bailey, K., Skarecky, D., Kwiatowski, J., & Ayala, F. J. (1994) · Genetics · doi:10.1093/genetics/136.4.1329 · Cited by 279
Copper Delivery by Metallochaperone Proteins
Rosenzweig, A. C. (2001) · Accounts of Chemical Research · doi:10.1021/ar000012p · Cited by 279
Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis
Hooten, K. G., Beers, D. R., Zhao, W., & Appel, S. H. (2015) · Neurotherapeutics · doi:10.1007/s13311-014-0329-3 · Cited by 275
“The following year, the human cassette containing the G93A mutation of SOD1 (mSOD1) was inserted into a mouse [3–5].”
MethodAP-HP, H. D. L. P.-S., & Gordon, P. (2013) · Aging and Disease · doi:10.14336/ad.2013.0400295 · Cited by 277
“Aging and Disease • Volume 4, Number 5, October 2013 298 The first mutation discovered was in the SOD1 gene on chromosome 21 [35].”
BackgroundIntermolecular transmission of superoxide dismutase 1 misfolding in living cells
Grad, L. I., Guest, W. C., Yanai, A., Pokrishevsky, E., O'Neill, M. A., Gibbs, E., Semenchenko, V., Yousefi, M., Wishart, D. S., Plotkin, S. S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102645108 · Cited by 274
“Approximately 10% of ALS cases display autosomal dominant inheritance (3), with ≈20% of these cases due to mutations in the gene encoding superoxide dismutase 1 (SOD1) (4), a ubiquitously expressed free radical defense enzyme abundantly expressed in motor neurons.”
BackgroundFurukawa, Y., & O'Halloran, T. V. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500482200 · Cited by 275
FTD and ALS: A Tale of Two Diseases
Ferrari, R., Kapogiannis, D., D. Huey, E., & Momeni, P. (2011) · Current Alzheimer Research · doi:10.2174/156720511795563700 · Cited by 272
Antisense oligonucleotides: translation from mouse models to human neurodegenerative diseases
Schoch, K. M., & Miller, T. M. (2017) · Neuron · doi:10.1016/j.neuron.2017.04.010 · Cited by 274
“OncemutantHtt is translated, the expanded polyglutamine (polyQ) protein likely mediates a toxic gain of function through the formation of intraneuronal aggregates or interaction with other proteins (Ordway et al., 1997; Rubinsztein, 2002).”
Mitochondria-Targeted Cytoprotective Peptides for Ischemia–Reperfusion Injury
Szeto, H. H. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1892 · Cited by 274
“About 20% of cases of familial amyotrophic lateral sclerosis carry this mutation (83), and motor neuron-like cells carrying this mutation have increased ROS production, increased lipid peroxidation, increased cytochrome c release, and reduced cell viability (34).”
The Role of Copper, Molybdenum, Selenium, and Zinc in Nutrition and Health
Chan, S., Gerson, B., & Subramaniam, S. (1998) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(18)30143-4 · Cited by 273
Effects of natural antioxidants in neurodegenerative disease
Albarracin, S. L., Stab, B., Casas, Z., Sutachan, J. J., Samudio, I., Gonzalez, J., Gonzalo, L., Capani, F., Morales, L., & Barreto, G. E. (2012) · Nutritional Neuroscience · doi:10.1179/1476830511y.0000000028 · Cited by 271
Free‐Radical Theory of Aging: Increasing the Functional Life Span
HARMAN, D. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb12069.x · Cited by 224
Costa, V (2001) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(01)00012-7 · Cited by 271
Reactive oxygen species and the regulation of cell death by the Bcl-2 gene family
Korsmeyer, S. J., Yin, X.-M., Oltvai, Z. N., Veis-Novack, D. J., & Linette, G. P. (1995) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(95)00011-r · Cited by 272
Down-regulation of copper/zinc superoxide dismutase causes apoptotic death in PC12 neuronal cells.
Troy, C. M., & Shelanski, M. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.14.6384 · Cited by 270
Martin, L. J., Liu, Z., Chen, K., Price, A. C., Pan, Y., Swaby, J. A., & Golden, W. C. (2007) · Journal of Comparative Neurology · doi:10.1002/cne.21160 · Cited by 269
“Autosomal dominant mutations in the superoxide dismutase 1 (SOD1, ALS1) gene occur in 20% of fALS cases (Rosen et al., 1993; Deng et al., 1993).”
BackgroundThe clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions
Simón-Sánchez, J., Dopper, E. G. P., Cohn-Hokke, P. E., Hukema, R. K., Nicolaou, N., Seelaar, H., de Graaf, J. R. A., de Koning, I., van Schoor, N. M., Deeg, D. J. H., et al. (2012) · Brain · doi:10.1093/brain/awr353 · Cited by 270
“…optineurin mutations in ALS, but fused in sarcoma, valosin-containing protein and TDP mutations are also occasionally found in patients with FTD (Rosen, 1993; Majoor-Krakauer et al., 1994; Hutton et al., 1998; Baker et al., 2006; Cruts et al., 2006; Gros-Louis et al., 2006; van Swieten and…”
BackgroundThe Copper Chaperone CCS Directly Interacts with Copper/Zinc Superoxide Dismutase
Casareno, R. L. B., Waggoner, D., & Gitlin, J. D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.37.23625 · Cited by 270
Batulan, Z., Shinder, G. A., Minotti, S., He, B. P., Doroudchi, M. M., Nalbantoglu, J., Strong, M. J., & Durham, H. D. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-13-05789.2003 · Cited by 269
“Approximately 20% of familial ALS (FALS) cases are caused by autosomal dominant mutations in Cu/Zn-superoxide dismutase (SOD-1) (Rosen et al., 1993).”
BackgroundBrettschneider, J., Toledo, J. B., Van Deerlin, V. M., Elman, L., McCluskey, L., Lee, V. M.-Y., & Trojanowski, J. Q. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039216 · Cited by 268
“survival [21–23].”
Urushitani, M., Kurisu, J., Tsukita, K., & Takahashi, R. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01211.x · Cited by 268
Bitanihirwe, B. K. Y., & Cunningham, M. G. (2009) · Synapse · doi:10.1002/syn.20683 · Cited by 265
Flavonoid-Based Therapies in the Early Management of Neurodegenerative Diseases
Solanki, I., Parihar, P., Mansuri, M. L., & Parihar, M. S. (2015) · Advances in Nutrition · doi:10.3945/an.114.007500 · Cited by 267
Mutant SOD1 causes motor neuron disease independent of copper chaperone–mediated copper loading
Subramaniam, J. R., Lyons, W. E., Liu, J., Bartnikas, T. B., Rothstein, J., Price, D. L., Cleveland, D. W., Gitlin, J. D., & Wong, P. C. (2002) · Nature Neuroscience · doi:10.1038/nn823 · Cited by 267
“Up to 10% of cases of ALS are familial (FALS), and ∼25% of these are linked to mutation in Cu/Zn superoxide dismutase, an antioxidant enzyme that protects cells against superoxide toxicit”
BackgroundGenetics of Amyotrophic Lateral Sclerosis
Ghasemi, M., & Brown, R. H. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024125 · Cited by 262
“3) (Rosen et al. 1993).”
Self-citationNitric Oxide in Health and Disease of the Nervous System
Knott, A. B., & Bossy-Wetzel, E. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2234 · Cited by 264
“As discussed earlier, ALS patients and transgenic mice exhibit increased concentrations of 3-nitrotyrosine in spinal cord neurons (7, 51, 124).”
GDNF Delivery Using Human Neural Progenitor Cells in a Rat Model of ALS
Klein, S. M., Behrstock, S., McHugh, J., Hoffmann, K., Wallace, K., Suzuki, M., Aebischer, P., & Svendsen, C. N. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.509 · Cited by 265
Yoshino, H., & Kimura, A. (2006) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960600881870 · Cited by 263
“The SOD1 gene was identified as a contributory factor in familial ALS (FALS) in 1993 (6).”
BackgroundEffects of chronic mild stress on the oxidative parameters in the rat brain
Lucca, G., Comim, C. M., Valvassori, S. S., Réus, G. Z., Vuolo, F., Petronilho, F., Dal-Pizzol, F., Gavioli, E. C., & Quevedo, J. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2009.01.001 · Cited by 265
D‐Serine is a key determinant of glutamate toxicity in amyotrophic lateral sclerosis
Sasabe, J., Chiba, T., Yamada, M., Okamoto, K., Nishimoto, I., Matsuoka, M., & Aiso, S. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601840 · Cited by 265
Suzuki, M., McHugh, J., Tork, C., Shelley, B., Hayes, A., Bellantuono, I., Aebischer, P., & Svendsen, C. N. (2008) · Molecular Therapy · doi:10.1038/mt.2008.197 · Cited by 262
“However, a clear genetic link to point mutations in the cytosolic Cu2+/Zn2+ superoxide dismutase 1 (SOD1) has been shown in a small group of familial ALS (FALS) patients [3,4].”
Troy, C., Derossi, D., Prochiantz, A., Greene, L., & Shelanski, M. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-01-00253.1996 · Cited by 265
“The observation that a subset of cases of familial amyotrophic lateral sclerosis (FALS) is associated with mis-sense mutations of SOD1 has provided the first molecular basis for involvement of this enzyme in neuronal degenerative disorders (Rosen et al., 1993).”
BackgroundDesnuelle, C., Dib, M., Garrel, C., & Favier, A. (2001) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608201300079364 · Cited by 264
TARDBP and FUS Mutations Associated with Amyotrophic Lateral Sclerosis: Summary and Update
Lattante, S., Rouleau, G. A., & Kabashi, E. (2013) · Human Mutation · doi:10.1002/humu.22319 · Cited by 265
“A major breakthrough in ALS research occurred in 1993 when the first gene was identified in FALS (FALS1) [Rosen et al., 1993].”
BackgroundSelf-citationAbe, K., Pan, L.-H., Watanabe, M., Kato, T., & Itoyama, Y. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12039-7 · Cited by 262
Bruening, W., Roy, J., Giasson, B., Figlewicz, D. A., Mushynski, W. E., & Durham, H. D. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720693.x · Cited by 263
Self-citationMutations in CHMP2B in Lower Motor Neuron Predominant Amyotrophic Lateral Sclerosis (ALS)
Cox, L. E., Ferraiuolo, L., Goodall, E. F., Heath, P. R., Higginbottom, A., Mortiboys, H., Hollinger, H. C., Hartley, J. A., Brockington, A., Burness, C. E., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009872 · Cited by 262
“This is approximately half of the frequency of SOD1 mutations, which have been reported to account for approximately 20% of familial ALS cases [41], and 2% of all ALS cases [42,43,44].”
BackgroundWiedemann, F. R., Winkler, K., Kuznetsov, A. V., Bartels, C., Vielhaber, S., Feistner, H., & Kunz, W. S. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00008-2 · Cited by 262
Microglia and neuroprotection: From in vitro studies to therapeutic applications
Polazzi, E., & Monti, B. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.06.009 · Cited by 262
Zhou, S.-F., Wang, B., Yang, L.-P., & Liu, J.-P. (2010) · Drug Metabolism Reviews · doi:10.3109/03602530903286476 · Cited by 262
“…and fatal neurodegenerative disease caused by the degeneration of motor neurons of the cortex, brainstem, and spinal cord and mutations in the gene that produces the Cu/Zn superoxide dismutase-1 (EC 1.15.1.1) are associated with ~20% of familial ALS (Logroscino and Armon, 2007; Rosen et al., 1993).”
BackgroundInfluentialShaw, P., & Eggett, C. J. (2000) · Journal of Neurology · doi:10.1007/bf03161151 · Cited by 261
Energy metabolism in ALS: an underappreciated opportunity?
Vandoorne, T., De Bock, K., & Van Den Bosch, L. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1835-x · Cited by 262
“The interest in the role of oxidative stress was nurtured for decades by the finding that mutations in SOD1 can cause ALS [159].”
BackgroundOligodendrocyte dysfunction in the pathogenesis of amyotrophic lateral sclerosis
Philips, T., Bento-Abreu, A., Nonneman, A., Haeck, W., Staats, K., Geelen, V., Hersmus, N., Küsters, B., Van Den Bosch, L., Van Damme, P., et al. (2013) · Brain · doi:10.1093/brain/aws339 · Cited by 260
“Mutations in superoxide dismutase 1 (SOD1) and hex- anucleotide repeats in C9orf72 are the most prevalent (Rosen et al., 1993; DeJesus-Hernandez et al., 2011).”
BackgroundRiluzole, Neuroprotection and Amyotrophic Lateral Sclerosis
Cheah, B. C., Vucic, S., Krishnan, A., & Kiernan, M. C. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710791163939 · Cited by 258
Awano, T., Johnson, G. S., Wade, C. M., Katz, M. L., Johnson, G. C., Taylor, J. F., Perloski, M., Biagi, T., Baranowska, I., Long, S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812297106 · Cited by 260
Vielhaber, S. (2000) · Brain · doi:10.1093/brain/123.7.1339 · Cited by 258
“…membrane-associated Mn-SOD levels in the SALS biopsies are the possible cause of the observed mtDNA alterations provides a basis to suggest a similar pathogenic mechanism for SALS and FALS [mutations in CuZn-SOD have been shown to be associated with FALS in ~10% of cases (Rosen et al., 1993)].”
BackgroundThe Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis
Imamura, K., Izumi, Y., Watanabe, A., Tsukita, K., Woltjen, K., Yamamoto, T., Hotta, A., Kondo, T., Kitaoka, S., Ohta, A., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf3962 · Cited by 256
The Ageing Brain: Molecular and Cellular Basis of Neurodegeneration
Azam, S., Haque, M. E., Balakrishnan, R., Kim, I.-S., & Choi, D.-K. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.683459 · Cited by 255
“Exposure to environmental stimulus like trauma, drugs or toxins have harsh consequences in later life including defective neuroplasticity and cognitive impairment (Schaefers and Teuchert-Noodt, 2016).”
BackgroundGenetic Neurodegenerative Diseases: The Human Illness and Transgenic Models
Price, D. L., Sisodia, S. S., & Borchelt, D. R. (1998) · Science · doi:10.1126/science.282.5391.1079 · Cited by 259
Stathopulos, P. B., Rumfeldt, J. A. O., Scholz, G. A., Irani, R. A., Frey, H. E., Hallewell, R. A., Lepock, J. R., & Meiering, E. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1237797100 · Cited by 258
Inhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS disease models
Armakola, M., Higgins, M. J., Figley, M. D., Barmada, S. J., Scarborough, E. A., Diaz, Z., Fang, X., Shorter, J., Krogan, N. J., Finkbeiner, S., et al. (2012) · Nature Genetics · doi:10.1038/ng.2434 · Cited by 258
“We isolated and cultured rodent primary cortical neurons and transfected them with three constructs: (1) mApple, (2) enhanced green fluorescent protein (EGFP) or TDP-43 fused to EGFP (TDP-43-EGFP), and (3) siRNA directed against Dbr1 (sR-Dbr1) or scrambled siRNA (sRSc).”
MethodApoptosis in neurodegenerative diseases: the role of mitochondria
Tatton, W. G., & Olanow, C. W. (1999) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(98)00167-4 · Cited by 257
The high affinity uptake system for excitatory amino acids in the brain
Danbolt, N. C. (1994) · Progress in Neurobiology · doi:10.1016/0301-0082(94)90033-7 · Cited by 257
Appel, S. H., Beers, D. R., & Henkel, J. S. (2010) · Trends in Immunology · doi:10.1016/j.it.2009.09.003 · Cited by 256
“SOD1 mutations cause fALS and transgenic animals overexpressing different SOD1 mutations (mSOD1) develop a chronic progressive motoneuron disease similar to human fALS [2,55-57] (Box 3).”
BackgroundGenetics of familial and sporadic amyotrophic lateral sclerosis
Gros-Louis, F., Gaspar, C., & Rouleau, G. A. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.01.004 · Cited by 255
Self-citationThe role of glial-specific Kir4.1 in normal and pathological states of the CNS
Nwaobi, S. E., Cuddapah, V. A., Patterson, K. C., Randolph, A. C., & Olsen, M. L. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1553-1 · Cited by 255
“Rapidly fatal disease is often the result of mutations in superoxide dismutase 1 (SOD1) [96].”
BackgroundInfluentialBlair, I. P., Williams, K. L., Warraich, S. T., Durnall, J. C., Thoeng, A. D., Manavis, J., Blumbergs, P. C., Vucic, S., Kiernan, M. C., & Nicholson, G. A. (2010) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.194399 · Cited by 255
“Of these familial cases, 10e20% are caused by mutations in the superoxide dismutase 1 gene (SOD1).(7) 8 The TARDBP gene, which encodes TDP-43, was also confidently linked to familial ALS, and rare mutations in this gene have now been described in both familial and sporadic ALS cases.”
BackgroundGasotransmitter hydrogen sulfide signaling in neuronal health and disease
Paul, B. D., & Snyder, S. H. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.11.019 · Cited by 253
“Of these, the most commonly studies is the G93A mutation, a gain of function mutation that aggregates and causes death of motor neurons [110, 111].”
BackgroundGenetics of amyotrophic lateral sclerosis: A review
Mathis, S., Goizet, C., Soulages, A., Vallat, J.-M., & Masson, G. L. (2019) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2019.02.030 · Cited by 253
Metadata
- Authors
- Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., Rahmani, Z., Krizus, A., McKenna-Yasek, D., Cayabyab, A., Gaston, S. M., Berger, R., Tanzi, R. E., Halperin, J. J., Herzfeldt, B., Van den Bergh, R., Hung, W.-Y., Bird, T., Deng, G., Mulder, D. W., Smyth, C., Laing, N. G., Soriano, E., Pericak–Vance, M. A., Haines, J., Rouleau, G. A., Gusella, J. S., Horvitz, H. R., & Brown, R. H.
- Affiliations
- Massachusetts General Hospital (US)
- Northwestern University (US)
- Montreal General Hospital (CA)
- Howard Hughes Medical Institute (US)
- North Shore University Hospital (US)
- University of Washington (US)
- Mayo Clinic (US)
- ORCID
- Venue
- Nature
- Published
- 1993-03-01
- Volume
- 362
- Issue
- 6415
- Pages
- 59-62
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2096386031
- Cited by
- 7,062
- References
- 42
- Citations by year
- 2026: 137 · 2025: 154 · 2024: 201 · 2023: 185 · 2022: 254 · 2021: 259 · 2020: 295 · 2019: 205 · 2018: 258 · 2017: 248 · 2016: 242 · 2015: 248 · 2014: 262 · 2013: 264 · 2012: 315
- FWCI
- 174.77
- Type
- journal article
- Language
- en
- Update notices
- correction (1993-07-22)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glutathione Transferases and Polymorphisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- amyotrophic lateral sclerosis, familial ALS, SOD1, Cu/Zn superoxide dismutase, missense mutations, genetic linkage, chromosome 21q, autosomal dominant inheritance, free radical toxicity, candidate genes, motor neuron degeneration
- MeSH terms
- Amino Acid Sequence, Amyotrophic Lateral Sclerosis, Animals, Base Sequence, Codon, DNA, Exons, Humans, Isoenzymes, Lod Score, Molecular Sequence Data, Mutation, Nucleic Acid Conformation, Oligodeoxyribonucleotides, Polymorphism, Genetic, Repetitive Sequences, Nucleic Acid, Superoxide Dismutase, Genome, Human, Polymerase Chain Reaction, Sequence Homology, Amino Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.